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Abstract
Background: Acute kidney injury (AKI) is a common complication in burn patients admitted to the intensive care
unit (ICU) associated with increased morbidity and mortality. Our primary aim was to review incidence, risk factors,
and outcomes of AKI in burn patients admitted to the ICU. Secondary aims were to review the use of renal
replacement therapy (RRT) and impact on health care costs.
Methods: We conducted a systematic search in PubMed, UpToDate, and NICE through 3 December 2018. All reviews
in Cochrane Database of Systematic Reviews except protocols were added to the PubMed search. We searched for
studies on AKI according to Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE); Acute
Kidney Injury Network (AKIN); and/or Kidney Disease: Improving Global Outcomes (KDIGO) criteria in burn patients
admitted to the ICU. We collected data on AKI incidence, risk factors, use of RRT, renal recovery, length of stay (LOS),
mortality, and health care costs.
Results: We included 33 observational studies comprising 8200 patients. Overall study quality, scored according to
the Newcastle-Ottawa scale, was moderate. Random effect model meta-analysis revealed that the incidence of AKI
among burn patients in the ICU was 38 (30–46) %. Patients with AKI were almost evenly distributed in the mild,
moderate, and severe AKI subgroups. RRT was used in 12 (8–16) % of all patients. Risk factors for AKI were high age,
chronic hypertension, diabetes mellitus, high Total Body Surface Area percent burnt, high Abbreviated Burn Severity
Index score, inhalation injury, rhabdomyolysis, surgery, high Acute Physiology and Chronic Health Evaluation II score,
high Sequential Organ Failure Assessment score, sepsis, and mechanical ventilation. AKI patients had 8.6 (4.0–13.2) days
longer ICU LOS and higher mortality than non-AKI patients, OR 11.3 (7.3–17.4). Few studies reported renal recovery, and
no study reported health care costs.
Conclusions: AKI occurred in 38% of burn patients admitted to the ICU, and 12% of all patients received RRT. Presence
of AKI was associated with increased LOS and mortality.
Trial registration: PROSPERO (CRD42017060420)
Keywords: Acute kidney injury, Burn, Critical illness, Risk factor, Mortality, Renal replacement therapy, Outcome,
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Background
Acute kidney injury (AKI) is a common complication in
burn patients admitted to the intensive care unit (ICU),
but incidence rates depend upon the burn population
studied and AKI definition used [1, 2]. Consensus defini-
tions of AKI are developed to include all severities of
AKI and allow comparison between studies; these are
the Risk, Injury, Failure, Loss of kidney function, and
End-stage kidney disease (RIFLE) [3]; Acute Kidney
Injury Network (AKIN) [4]; and Kidney Disease: Improv-
ing Global Outcomes (KDIGO) criteria [5].
Several risk factors for AKI are identified in burn pa-
tients such as high age, burn injury extent and/or mech-
anism, and presence of multiple organ failure and/or
sepsis [2]. However, the results of prophylactic strategies
have so far mostly been disappointing [6]. AKI is a het-
erogeneous condition ranging from subclinical decline in
kidney function to need of renal replacement therapy
(RRT). Despite development of international treatment
guidelines [5], the practical handling of AKI, and use of
RRT, varies substantially across the world [7].
AKI in burn patients is associated with increased mor-
tality [2, 8] and probably also increased length of stay
(LOS) [2]. From other patient groups, it has become evi-
dent that survivors of AKI are prone to developing
chronic kidney disease (CKD) and have increased long-
term morbidity and mortality [9]. AKI may also be a
burden to the health care system, leading to substantially
increased treatment costs, especially related to use of
RRT [10].
The purpose of the present study was to review inci-
dence, risk factors, and outcomes of AKI in burn pa-
tients admitted to the ICU. Secondary aims were to
review the use of renal replacement therapy (RRT) and
impact on health care costs.
Methods
Study registration
This systematic review and meta-analysis was registered
in the PROSPERO database on 12 May 2017
(CRD42017060420) [11]. We report results according to
the PRISMA guidelines (Additional file 1).
Data sources and search strategy
We searched papers published between 1 January 2004
and 3 December 2018 in PubMed, UpToDate, and
National Institute for Health and Care Excellence
(NICE). All reviews in Cochrane Database of Systematic
Reviews except protocols were added to the PubMed
search. Searches in PubMed consisted of Medical
Subject Headings and text words including acute kid-
ney injury and burn. We searched for ongoing system-
atic reviews in PROSPERO and conducted hand
searches of reference lists.
The search focused on the study population, irrespect-
ive of reported intervention, comparison, and outcome.
Inclusion was limited to studies of burn patients admit-
ted to an ICU, reporting on AKI as defined by full or
modified RIFLE, AKIN, and/or KDIGO criteria. Only
publications in English or Scandinavian languages were
considered (Additional file 2).
Study selection
Two collaborators (KMN and CKT) independently
screened studies for eligibility according to pre-defined
study selection criteria (Additional file 3). Titles, ab-
stracts, and keywords were examined, and full texts were
obtained for all potentially relevant records. Studies on
trauma patients without burns were excluded as findings
are presented elsewhere [12]. Empirical studies compar-
ing AKI and non-AKI patients were included; case re-
ports excluded. Any disagreement was resolved through
discussion with a senior author (SB).
Data extraction
Two independent collaborators (TF and SB) extracted
data in duplicate according to a pre-defined data extrac-
tion form (Additional file 4). In cases where data points
were missing or ambiguously reported, the first and last
author of the study were contacted by e-mail up to two
times to obtain data. For each study, we extracted de-
tailed information about study sampling, i.e. if the pa-
tients were recruited consecutively from an intensive
care unit or if the study sample was more narrowly
defined.
We extracted data on days to AKI, criteria used, inci-
dence rates, and severity including use of RRT. Many
risk factors were assessed, including body mass index
(BMI), mean arterial pressure (MAP), Total Body
Surface Area (TBSA) percent burnt [13], Abbreviated
Burn Severity Index (ABSI) [14], Simplified Acute
Physiology Score (SAPS) [15], Acute Physiology and
Chronic Health Evaluation (APACHE) [16] score, and
Sequential Organ Function Assessment (SOFA) score
[17] (Additional file 5). Collected outcome data were
renal recovery, ICU and hospital LOS, and mortality.
Assessment of study quality
Two authors (TF and SB) independently assessed the
risk of bias of each included study using the Newcastle-
Ottawa quality assessment scale [18].
Quantitative data synthesis
Meta-analyses and forest plots were prepared in R [19]
using the meta [20] and the forest plot [21] packages.
We used random effect models with the DerSimonian-
Laird estimator since we expected some heterogeneity
between studies. Continuous and dichotomous risk
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factors and outcomes were compared in patients with
and without AKI by calculating mean differences (MD)
and odds ratios (OR), respectively. Data primarily re-
ported as medians with interquartile ranges were re-
expressed into means and standard deviations (SDs) as
suggested in the Cochrane handbook [22]. Studies
reporting distribution of data only as ranges were ex-
cluded from the meta-analyses.
Meta-analyses of proportions were performed on
arcsine-transformed data. In an attempt to limit in-
between study heterogeneity, it was decided post hoc
that meta-analyses of proportions should be confined to
studies applying consecutive or random data sampling
methods. In contrast, all studies were included in meta-
analyses based on the use of control groups.
Risk factors potentially associated with development of
AKI were explored in pooled analyses if reported in three
or more studies. We generated a forest plot containing
summary estimates for multiple risk factors. For dichot-
omous risk factors, ORs were calculated using the meta
package in R. Continuous risk factors were expressed as
standardised mean differences (SMDs) using the meta
package in R and transformed to OR according to the for-
mula suggested in the Cochrane handbook [23].
Subgroup analyses
We analysed subgroups on mild (RIFLE R, AKIN 1,
KDIGO 1), moderate (RIFLE I, AKIN 2, KDIGO 2), and
severe (RIFLE F, AKIN 3, KDIGO 3) AKI, and use of
RRT.
Evaluation of heterogeneity
Statistical heterogeneity among studies was assessed with
Cochran’s Q test [22] and quantified by the I2 statistic
describing the proportion of total variation due to het-
erogeneity rather than chance [24, 25].
Results
Study selection
We identified 1106 unique studies from the literature
search and screened their abstracts. Thirty-three of
286 potentially eligible studies were included in the
qualitative and quantitative data synthesis [26–58]
(Fig. 1). We requested additional data from the au-
thors of nine publications, whereof four provided data
[47, 55, 56, 58], one did not have the data [36], and
four did not respond [35, 51, 52, 54].
Study characteristics
All 33 included studies were observational with cohort
design published in medical journals with English lan-
guage in article or letter form. Most studies were on
adults with variable burn mechanism and extent. AKI
criteria were RIFLE, AKIN, and KDIGO in 18, seven and
eight studies, respectively. Eleven studies used original
AKI criteria, whereas the remaining used different
Fig. 1 Flow chart of search results according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) guidelines. ICU,
intensive care unit; AKI, acute kidney injury
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versions of modified criteria (n = 20), or did not describe
the use of criteria (n = 2) (Table 1).
The included studies comprised data from 8200 pa-
tients, and 18 of the studies had consecutive sampling of
patients. In six of the papers, we selected only patients
who had comparison between AKI and non-AKI
(Table 1). Most studies reported mean or median age
between 30 and 60 years. Male participants ranged from
54 to 100%, and average TBSA percent burnt ranged
from 16 to above 70%.
Table 1 Characteristics of included studies on acute kidney injury in burn patients














Lopes JA, 2007 Adults, severe No RIFLE Original PCS 10 days n.a.
Coca SG, 2007 Adults, > 10% Yes RIFLE Modifiedc RCS Hospital 81/304
Steinvall I, 2008 Adults, > 20% Yes RIFLE Original PCS Hospital 31/127
Mariano F, 2008 Adults, severe No RIFLE Unknown PCS 19 days n.a.
Palimeri T, 2009 Children, > 10% Yes RIFLE Modifiedd RCS Hospital 56/123
Palimeri T, 2010 Adults, > 20% Yes RIFLE Original RCS Intensive 32/60
Mosier MJ, 2010 Adults, > 20% No RIFLE Modifiede RCS 24 h n.a.
Schneider DF, 2012 Adults, > 20% No RIFLE Modifiede RCS 48 h n.a.
Chung KK, 2012 Adults, unknown Yes AKIN Modifiedc RCS Hospital 656/1973
Hu JY, 2012 Adults, > 30% Yes RIFLE Original RCS Hospital 151/396
Stewart IJ, 2013 Adults, burn ICU No AKIN Modifiedc RCS Hospital n.a.
Hong DY, 2013 Adults, > 20% Yes RIFLE Original PCS Hospital 11/45
Yang HT, 2014 Adults, > 20% Yes RIFLE Modifiede PCS 5 days 31/66
Yavuz S, 2014 Children, > 10% No RIFLE Original PCS 48 h n.a.
Noshad H, 2014 Adults, unknown No RIFLE Unknown PCS Unknown n.a.
Howell E, 2015 Adults, > 20% No RIFLE Modifiede PCS 48 h n.a.
Sen S, 2015 Adults, > 20% No RIFLE Modifiedf PCS 7 days n.a.
Ren H, 2015 Adults,> 10% No KDIGO Modifiede,g PCS 48 h n.a.
Liang I, 2015 Adults, > 40% No RIFLE Modifiede PCS 2 days n.a.
Yim H, 2015 Adults, major Yes AKIN Original PCS 28 days 40/97
Kym D, 2015 Adults, > 20% Yes RIFLE Original PCS Intensive 48/85
Queiroz LF, 2016 Adults, burn ICU Yes KDIGO Modifiedc RCS Intensive 77/293
Rakkolainen I, 2016 Adults, > 15% Yes AKIN Modifiedc PCS Intensive 9/19
Sanches-Sanches M, 2016 Adults, > 15% No AKIN Original PCS Intensive n.a.
Kuo G, 2016 Adults, severe Yes KDIGO Modifiede RCS 3 days 52/145
Hundeshagen G, 2017 Mix, burn centre Yes KDIGO Modifiedc RCS 7 days 88/718
Kumar AB, 2017 Adults, > 20% No AKIN Modifiedc RCS 5 days n.a.
Kimmel LA, 2018 Adults, > 10% Yes RIFLE Modifiedc RCS Unknown 60/267
Chun W, 2018 Adults, > 20% Yes AKIN Original PCS 28 days 32/76
Depret F, 2018 Adults, > 20% Yes KDIGO Original PCS Hospital 55/87
Talizin TB, 2018 Adults, > 20% No KDIGO Modifiedc PCS 7 days n.a.
Kim HY, 2019 Adults, surgery No KDIGO Modifiedc RCS 7 days n.a.
Clark AT, 2019 Adults, burn ICU Yes KDIGO Modifiedc RCS Hospital 601/1040
AKI acute kidney injury, N number, RIFLE Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease, AKIN Acute Kidney Injury Network, KDIGO
Kidney Disease: Improving Global Outcomes, PCS prospective cohort study, RCS retrospective cohort study, ICU intensive care unit, n.a not applicable
aNumbers are percent burn injury of Total Body Surface Area
bNumbers are minimal follow-up time for AKI
cStudy used only creatinine criteria and not urine output criteria
dStudy used paediatric version of criteria
eStudy used shorter follow-up time than the criteria
fStudy only used injury and failure according to RIFLE criteria
gStudy only used serum creatinine increase ≥ 26.5 μmol/L within 48 h
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Assessment of study quality
Overall study quality, scored according to the
Newcastle-Ottawa scale, was moderate. The study popu-
lation consisted of unselected major burn patients in 25
studies, and all studies had comparable control groups.
Eleven studies excluded patients with CKD, and 20 stud-
ies omitted patients on chronic RRT. Twenty-three stud-
ies controlled for confounding factors when comparing
groups. Eight of the studies had too short, or unde-
scribed, follow-up time for AKI to occur. Assessment of
outcomes was overall satisfactory, but only one study ex-
plicitly reported loss to follow-up (Additional file 6). No
studies were excluded from our quantitative synthesis
due to high risk of bias.
Quantitative data synthesis
Incidence rates
Pooled analysis of 18 studies (5921 patients) with con-
secutive sampling of patients revealed an overall inci-
dence of AKI of 38 (30–46) % (Fig. 2). Time from burn
injury to AKI diagnosis ranged from 1 to 17 days [36, 37,
45, 46, 53]. In the 13 studies reporting incidence rates by
AKI severity, 10 (4–18) %, 8 (6–11) %, and 13 (10–17) %
had mild, moderate, and severe AKI, respectively (Add-
itional files 7, 8, and 9).
Risk factors
Risk factors for AKI were reported in 29 studies with
7229 patients (Additional file 5), and pooled analyses
yielded crude effect estimates for the different risk fac-
tors. High age, chronic hypertension, diabetes mellitus,
high TBSA percent burnt, high ABSI score, inhalation
injury, rhabdomyolysis, surgery, high APACHE II score,
high SOFA score, sepsis, and mechanical ventilation
were associated with increased risk of AKI (Fig. 3).
We were unable to quantify the impact of several
relevant risk factors because they were reported in
fewer than three studies; these included African
American descent, body weight, pre-existing coronary
artery disease, congestive heart failure and liver fail-
ure, SAPS II score, intraabdominal hypertension, cir-
culatory shock, hypotension, number and duration of
surgical procedures, and escharotomy (Add-
itional file 5). Additional risk factors could not be
analysed because studies reported zero events in both
groups; these were pre-existing kidney disease, ab-
dominal compartment syndrome, and chemical injury.
Studies reporting median age were excluded because
the conversion of median values to means tended to
overestimate the risk association. Use of mechanical
ventilation and ventilator time were correlated, and
we report the use of mechanical ventilation.
Renal replacement therapy
RRT was reported in 13 studies (4357 patients) with
consecutive sampling of patients and used in 12 (8–16)
% of all burn patients (Additional file 10). RRT modes
Fig. 2 Reported incidence rates of acute kidney injury (AKI) in burn patients admitted to the intensive care unit. N, number of patients in the
study; CI, confidence interval; RE, random effect
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were continuous RRT [38, 45, 46, 54, 55], intermittent
haemodialysis [47], or unspecified [27, 28, 34, 37, 48, 50, 58].
Length of stay
Nine studies (3069 patients) reported ICU LOS, and 13
studies (4694 patients) hospital LOS. Patients with AKI
had 8.6 (4.0–13.2) days longer ICU LOS (Add-
itional file 11) and 10.5 (4.8–16.3) days longer hospital
LOS (Additional file 12), compared to non-AKI patients.
Mortality
Pooled analysis of 16 studies (1872 AKI patients) re-
vealed that mortality in AKI patients was 43 (32–56) %,
but varied considerably across studies (Additional file 13).
Mortality was much higher in AKI compared to non-
AKI patients, with an OR of 11.3 (7.3–17.4) (Fig. 4).
Renal recovery
Renal recovery was reported in two studies (42 AKI pa-
tients) with consecutive sampling of patients
Fig. 3 Risk factors for acute kidney injury in burn patients admitted to the intensive care unit. The contribution from the various risk factors were
statistically weighted and adjusted to a single scale. Odds ratios (OR) for continuous risk factors were derived from standardised mean differences.
CI, confidence interval; ABSI, Abbreviated Burn Severity Index; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ
Function Assessment; TBSA, Total Body Surface Area; BMI, body mass index; MAP, mean arterial pressure
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(Additional file 14), and all patients except two had nor-
mal kidney function at discharge [28, 37].
Health care costs
None of the studies reported health care costs of AKI.
Subgroup analyses
Seven studies (886 AKI patients) reported mortality in
the different AKI severity groups. Pooled mortality in
mild, moderate, and severe AKI was 14 (7–24) %, 21 (8–
38) %, and 67 (51–81) % (Additional files 15, 16, and
17), respectively. AKI compared to non-AKI patients
had OR for death of 3.9 (2.0–7.5), 11.1 (5.6–21.6), and
43.0 (23.5–78.8) in mild, moderate, and severe AKI, re-
spectively (Additional files 18, 19, and 20).
Five studies (175 RRT patients) reported that patients
undergoing RRT had a mortality rate of 74 (58–87) %
(Additional file 21). Six studies (200 RRT patients)
revealed that RRT patients had OR for mortality 60.4
(20.1–181.5) compared to non-AKI patients
(Additional file 22).
Sensitivity analyses
It was decided post hoc that meta-analyses of propor-
tions should be confined to studies that applied consecu-
tive or random data sampling methods, and we therefore
performed sensitivity analyses in which all studies were
included. Briefly, the results remain similar even though
all studies were included. For example, the incidence of
AKI remained 38% and mortality among AKI patients
remained 43% when all studies were included in the
meta-analysis.
Heterogeneity
Heterogeneity varied considerably between the meta-
analyses. Extensive heterogeneity with Cochran’s Q test
p < 0.0001 and Higgins’ I2 > 90% was observed in most
meta-analyses of proportions. Cochran’s Q test also indi-
cated heterogeneity in most analyses of rates and differ-
ences, but usually with lower Higgins’ I2 scores. I2 was
72% when comparing mortality between AKI and no
AKI groups and 77% for the analysis of ICU LOS. It is
likely that a large part the observed heterogeneity can be
attributed to differences between the available study
Fig. 4 Mortality in burn patients with acute kidney injury (AKI) in the intensive care unit. Odds ratio (OR) for mortality reported at any time point
is compared in AKI and non-AKI patients. N AKI, number of AKI patients; CI, confidence interval; RE, random effect
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samples. For example, we show that the mortality in-
creases with the severity of AKI, but the distribution of
AKI severity is unknown in many studies. The presence
and absence of other risk factors also vary considerably
between the included studies, but these differences are
difficult to control for without access to individual pa-
tient data.
Discussion
This systematic review reveals that AKI occurs in ap-
proximately 38% of burn patients admitted to the ICU,
with use of RRT in 12% of all patients. Burn patients at
risk for AKI have high age, chronic hypertension, dia-
betes mellitus, high TBSA percent burnt, high ABSI
score, inhalation injury, rhabdomyolysis, surgery, high
APACHE II score, high SOFA score, sepsis, and mech-
anical ventilation. Development of AKI after burn is as-
sociated with prolonged stay in ICU and hospital, and
reduced chance of survival. Kidney function seems to re-
cover well in most burn patients with AKI. Notably, no
study reported the economic consequences of AKI after
burns.
A previous study of mixed ICU patients observed that
57% of the patients experienced AKI according to the
KDIGO criteria, and 13.5% underwent RRT [59]. In a
meta-analysis of burn patients assessed by the RIFLE cri-
teria, AKI was present in 30–66% of the patients, and
RRT used in 5% [8]. In comparison, this systematic re-
view using several criteria revealed 38% with AKI and
12% treated with RRT. The incidence of AKI and use of
RRT varied widely among the included studies; this may
partly be explained by large differences in burn popula-
tions. It is likely, however, that many of the studies in
this systematic review underreported the incidence of
AKI due to the use of modified AKI criteria.
High age, chronic hypertension, and diabetes mellitus
are known risk factors for AKI [12, 59]. An earlier meta-
analysis found that inhalation injury, high TBSA percent
burnt, and high ABSI score were risk factors for AKI
after burn [2]. Our data suggest that rhabdomyolysis and
surgery are additional burn-related risk factors. AKI is
often present in the most severely ill patients as indi-
cated by high APACHE II and SOFA scores [2, 12].
Sepsis and use of mechanical ventilation have also previ-
ously been associated with increased risk of AKI in crit-
ically ill patients [2, 60, 61].
AKI in ICU patients is often part of multiple organ
failure [1, 62, 63]. In line with this, we observed that pa-
tients with AKI had more than one week longer ICU
and hospital LOS compared to non-AKI patients. A
similar observation was recently observed in a meta-
analysis of major trauma patients [12]. The effect on
LOS in our systematic review may be underestimated,
since patients with AKI might have a high early mortal-
ity not adjusted for in many of the included studies.
In the present study, AKI after burns was associated
with several-fold increased mortality that was worsened
with the severity of AKI disease. A previous systematic
review of burn patients with AKI according to the RIFLE
criteria reported a mortality rate of 35% [8]. When ap-
plying several AKI criteria, we found that 43% of burn
patients with AKI died, and 74% of patients undergoing
RRT. In comparison, mortality was 27% in a study of
general ICU patients with AKI [59].
Evaluation of renal recovery is challenging because the
definition may vary from full recovery of functional re-
serve to RRT independence [64]. In our systematic re-
view, only two studies with consecutive sampling of
patients reported renal recovery; these reported that all
patients except two had normal kidney function at dis-
charge. This finding should be interpreted with caution
due to limited number of patients and insufficient
follow-up time to evaluate long-term effects. Previous
research suggests that ICU patients with AKI have in-
creased risk of CKD and all-cause mortality compared to
patients without AKI [9].
None of the studies reported the economic conse-
quences of AKI after burns. Despite this, one would as-
sume that both prolonged LOS and use of RRT would
increase treatment costs [65].
This systematic review has a number of clinical limita-
tions. The included studies had large clinical heterogen-
eity because the study participations and outcome
variables varied widely. AKI incidence may be underesti-
mated since many studies used modified AKI criteria.
Creatinine levels and urine output are influenced by
fluid and/or diuretic therapy not reported in most of the
studies. Data on hospital and ICU outcomes are influ-
enced by the local policy for transfer of patients, with-
holding or withdrawing therapy. The handling of AKI,
and particularly the use of RRT, probably varied across
sites [66]. Finally, the applicability of the results on renal
recovery may be impaired by variable case definitions
and short follow-up times.
Methodological limitations are that some publications
may have been missed due to language limitation of the
literature search. Complete datasets could not be ob-
tained from five studies. Many of our meta-analyses are
characterised by substantial statistical heterogeneity, and
hence, many summary estimates are uncertain with wide
confidence intervals. This heterogeneity is probably
caused by heterogeneity in study populations and study
design. We have carried out a large number of subgroup
analyses aiming to explore what causes the heterogen-
eity, but it was impossible to single out factors of par-
ticular importance. It seems likely that many factors play
a role and that the uncertainty would be reduced if we
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were able to control for confounding variables and
present adjusted summary estimates. Unfortunately, this
was not possible without access to individual patient
data. We did not formally evaluate potential bias that
may be caused by use of means and SDs for skewed vari-
ables in our analyses of risk factors. Finally, we were un-
able to include data on economic costs because of
missing data.
Strengths of this systematic review are the high num-
ber of included studies and patients. Further, the litera-
ture search, study selection, and data extraction were
determined and published before study start. Two inde-
pendent collaborators in duplicate screened studies for
eligibility, evaluated quality, and extracted data accord-
ing to pre-set criteria. Finally, we contacted authors
twice by e-mail in order to retrieve complete data from
eligible publications.
An implication of this systematic review for clinical
practice is that health care personnel should be aware of
burn patients at risk for AKI, for instance elderly pa-
tients with chronic hypertension, diabetes mellitus, and
extensive burn injuries. Future studies should explore
long-term patient outcomes and treatment costs of AKI
among burn victims. There is a clear need for develop-
ment of uniform standards of reporting in AKI, espe-
cially a consensus definition of renal recovery [64, 67].
Conclusions
The present systematic review reveals that AKI and use of
RRT is common in ICU patients with burn injuries. Pa-
tients with high age, chronic hypertension, diabetes melli-
tus, high TBSA percent burnt, high ABSI score, inhalation
injury, rhabdomyolysis, surgery, high APACHE II score,
high SOFA score, sepsis, and need for mechanical ventila-
tion are at risk for post-burn AKI. Development of AKI
after burn has a negative impact on short-time morbidity
and mortality, but we lack data on long-term patient out-
comes and economic consequences. Limited data suggests
that most survivors of AKI regain their kidney function.
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Figure showing the mortality of patients with severe acute kidney injury
(AKI). N: Number of patients with AKI, CI: confidence interval, RE: random
effect.
Additional file 18. Odds ratio for mortality in patients with mild acute
kidney injury. Figure showing the odds ratio (OR) for mortality in patients
with mild acute kidney injury (AKI) compared to patients without AKI. N:
Number of patients with AKI, CI: confidence interval, RE: random effect.
Additional file 19. Odds ratio for mortality in patients with moderate
acute kidney injury. Figure showing the odds ratio (OR) for mortality in patients
with moderate acute kidney injury (AKI) compared to patients without AKI. N:
Number of patients with AKI, CI: confidence interval, RE: random effect.
Additional file 20. Odds ratio for mortality in patients with severe acute
kidney injury. Figure showing the odds ratio (OR) for mortality in patients
with severe acute kidney injury (AKI) compared to patients without AKI.
N: Number of patients with AKI, CI: confidence interval, RE: random effect.
Additional file 21. Absolute mortality in patients with renal
replacement therapy. Figure showing absolute mortality of patients
undergoing renal replacement therapy. N: Number of patients on renal
replacement therapy, CI: confidence interval, RE: random effect.
Additional file 22. Odds ratio for mortality in patients undergoing renal
replacement therapy. Figure showing odds ratio (OR) for mortality in
patients undergoing renal replacement therapy (RRT) compared to
patients without acute kidney injury. N RRT: Number of patients on RRT,
CI: confidence interval, RE: random effect.
Folkestad et al. Critical Care            (2020) 24:2 Page 9 of 11
Abbreviations
ABSI: Abbreviated Burn Severity Index; AKI: Acute kidney injury; AKIN: Acute
Kidney Injury Network; APACHE: Acute Physiology and Chronic Health
Evaluation; BMI: Body mass index; CI: Confidence interval; CKD: Chronic
kidney disease; ICU: Intensive care unit; KDIGO: Kidney Disease: Improving
Global outcomes; LOS: Length of stay; MAP: Mean arterial pressure;
MD: Mean difference; N: Number; NICE: National Institute for Health and Care
Excellence; OR: Odds ratio; PRISMA: Preferred Reporting Items for Systematic
reviews and Meta-Analysis; RE: Random effect; RIFLE: Risk, Injury, Failure, Loss
of kidney function, and End-stage kidney disease; RRT: Renal replacement
therapy; SAPS: Simplified Acute Physiology Score; SD: Standard deviation;
SMD: Standardised mean difference; SOFA: Sequential Organ Function
Assessment; TBSA: Total Body Surface Area
Acknowledgements
The authors are grateful to senior medical librarian Marie Susanna Isachsen
for performing the literature search and documenting the search strategy.
Authors’ contributions
KGB and SB contributed to the conception and design of the study. KMN
and CKT selected the studies. TF and SB extracted the data and evaluated
the study quality. KGB was responsible for the statistical analyses and data
presentation. ABG contributed with experience in handling of burn injuries,
and IO with expertise in management of acute kidney injury. SB drafted the
manuscript; all authors participated in the interpretation of data and writing
of the manuscript. All authors read and approved the final manuscript.
Funding
The authors’ institutions only funded this study.
Availability of data and materials
The datasets generated and analysed during the current study are available
from the corresponding author upon a reasonable request.





The authors declare that they have no competing interests.
Author details
1Department of Anaesthesiology and Intensive Care Medicine, Haukeland
University Hospital, Bergen, Norway. 2Centre for Evidence Based Practice,
Western Norway University of Applied Sciences, Bergen, Norway. 3Division
for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
4Faculty of Medicine, University of Oslo, Oslo, Norway. 5Department of
Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
6Renal Research Group Ullevål, Institute of Clinical Medicine, Faculty of
Medicine, University of Oslo, Oslo, Norway. 7Division of Medicine,
Department of Nephrology, Oslo University Hospital, Oslo, Norway. 8Division
of Emergencies and Critical Care, Department of Anaesthesiology, Oslo
University Hospital, Oslo, Norway.
Received: 6 July 2019 Accepted: 16 December 2019
References
1. Clark A, Neyra JA, Madni T, Imran J, Phelan H, Arnoldo B, et al. Acute kidney
injury after burn. Burns. 2017;3:898–908.
2. Wu G, Xiao Y, Wang C, Hong X, Sun Y, Ma B, et al. Risk factors for acute
kidney injury in patients with burn injury: a meta-analysis and systematic
review. J Burn Care Res. 2017;38:271–82.
3. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure -
definition, outcome measures, animal models, fluid therapy and information
technology needs: the Second International Consensus Conference of the
Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.
4. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al.
Acute Kidney Injury Network: report of an initiative to improve outcomes in
acute kidney injury. Crit Care. 2007;11:R31.
5. Kidney Disease: Improving Global Outcomes KDIGO Acute Kidney Injury
Work Group: KDIGO clinical practice guideline for acute kidney injury.
Kidney Int Suppl. 2012;2:1–138.
6. Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al.
Prevention of acute kidney injury and protection of renal function in the
intensive care unit: update 2017: expert opinion of the Working Group on
Prevention, AKI section, European Society of Intensive Care Medicine.
Intensive Care Med. 2017;43:730–49.
7. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al.
Continuous renal replacement therapy: a worldwide practice survey. The
beginning and ending supportive therapy for the kidney (B.E.S.T. kidney)
investigators. Intensive Care Med. 2007;33:1563–70.
8. Brusselaers N, Monstrey S, Colpaert K, Decruyenaere J, Blot SI, Hoste EA.
Outcome of acute kidney injury in severe burns: a systematic review and
meta-analysis. Intensive Care Med. 2010;36:915–25.
9. See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR,
et al. Long-term risk of adverse outcomes after acute kidney injury: a
systematic review and meta-analysis of cohort studies using consensus
definitions of exposure. Kidney Int. 2019;95:160–72.
10. Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. Cost of acute renal
replacement therapy in the intensive care unit: results from The Beginning
and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit
Care. 2010;14:R46.
11. Nordhuus KMB, Tveiten CK, Isachsen MS, Brurberg KG, Søvik S, Eken T, et al:
Study protocol for systematic review: acute kidney injury in trauma patients
admitted to the ICU: a systematic review and meta-analysis. Availabe at:
https://www.crd.york.ac.uk/PROSPEROFILES/60420_PROTOCOL_20170412.
pdf. Accessed 8 May 2019.
12. Sovik S, Isachsen MS, Nordhuus KM, Tveiten CK, Eken T, Sunde K, et al.
Acute kidney injury in trauma patients admitted to the ICU: a systematic
review and meta-analysis. Intensive Care Med. 2019;45:407–19.
13. Moore RA, Burns B: Rule of Nines. Available at: https://www.ncbi.nlm.nih.
gov/books/NBK513287/. Accessed May 2, 2019.
14. Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann
Emerg Med. 1982;11:260–2.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology
Score (SAPS II) based on a European/North American multicenter study.
JAMA. 1993;270:2957–63.
16. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG,
et al. The APACHE III prognostic system. Risk prediction of hospital mortality
for critically ill hospitalized adults. Chest. 1991;100:1619–36.
17. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al.
Use of the SOFA score to assess the incidence of organ dysfunction/failure
in intensive care units: results of a multicenter, prospective study. Working
group on “sepsis-related problems” of the European Society of Intensive
Care Medicine. Crit Care Med. 1998;26:1793–800.
18. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al: The
Newcastle–Ottawa scale (NOS) for assessing the quality of nonrandomised
studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_
epidemiology/oxford.asp. Accessed 2 May 2019.
19. R Core Team: R: a language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria. Availabe at: https://
www.R-project.org. Asseessed 7 May 2019.
20. Schwarzer G: Meta: general package for meta-analysis, R Package Version 4.
3–2. Availabe at:https://CRAN.R-project.org/package=meta. Asseessed 13
May 2019.
21. Gordon M, Lumley T: forestplot: Advanced forest plot using “grid” graphics.
R package version 1.7. Availabe at: https://CRAN.R-project.org/package=
forestplot. Asseessed 13 May 2019.
22. Higgins JPT, Deeks JJ: Chapter 7: selecting studies and collecting data. In:
Higgins JPT, Green S (Eds) Cochrane handbook for systematic reviews of
interventions version 5.1.0. The Cochrane Collaboration. Available at: www.
handbook.cochrane.org. Accessed 9 May 2019.
23. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al:
Chapter 12: interpreting results and drawing conclusions. In: Higgins JPT,
Green S (Eds) Cochrane handbook for systematic reviews of interventions
version 5.1.0. The Cochrane Collaboration Available at: www.handbook.
cochrane.org. Accessed 2 May 2019.
Folkestad et al. Critical Care            (2020) 24:2 Page 10 of 11
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in
meta-analyses. BMJ. 2003;327:557–60.
25. Sedgwick P. Meta-analyses: what is heterogeneity? BMJ. 2015;350:h1435.
26. Lopes JA, Jorge S, Neves FC, Caneira M, da Costa AG, Ferreira AC, et al. An
assessment of the RIFLE criteria for acute renal failure in severely burned
patients. Nephrol Dial Transplant. 2007;22:285.
27. Coca SG, Bauling P, Schifftner T, Howard CS, Teitelbaum I, Parikh CR.
Contribution of acute kidney injury toward morbidity and mortality in
burns: a contemporary analysis. Am J Kidney Dis. 2007;49:517–23.
28. Steinvall I, Bak Z, Sjoberg F. Acute kidney injury is common, parallels organ
dysfunction or failure, and carries appreciable mortality in patients with
major burns: a prospective exploratory cohort study. Crit Care. 2008;12:R124.
29. Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, et al.
Circulating plasma factors induce tubular and glomerular alterations in
septic burns patients. Crit Care. 2008;12:R42.
30. Palmieri T, Lavrentieva A, Greenhalgh D. An assessment of acute kidney
injury with modified RIFLE criteria in pediatric patients with severe burns.
Intensive Care Med. 2009;35:2125–9.
31. Palmieri T, Lavrentieva A, Greenhalgh DG. Acute kidney injury in critically ill
burn patients. Risk factors, progression and impact on mortality. Burns. 2010;
36:205–11.
32. Mosier MJ, Pham TN, Klein MB, Gibran NS, Arnoldo BD, Gamelli RL, et al.
Early acute kidney injury predicts progressive renal dysfunction and higher
mortality in severely burned adults. J Burn Care Res. 2010;31:83–92.
33. Schneider DF, Dobrowolsky A, Shakir IA, Sinacore JM, Mosier MJ, Gamelli RL.
Predicting acute kidney injury among burn patients in the 21st century: a
classification and regression tree analysis. J Burn Care Res. 2012;33:242–51.
34. Chung KK, Stewart IJ, Gisler C, Simmons JW, Aden JK, Tilley MA, et al. The
Acute Kidney Injury Network (AKIN) criteria applied in burns. J Burn Care.
2012;33:483–90.
35. Hu JY, Meng XC, Han J, Xiang F, Fang YD, Wu J, et al. Relation between
proteinuria and acute kidney injury in patients with severe burns. Crit Care.
2012;16:R172.
36. Stewart IJ, Cotant CL, Tilley MA, Huzar TF, Aden JK, Snow BD, et al.
Association of rhabdomyolysis with renal outcomes and mortality in burn
patients. J Burn Care Res. 2013;34:318–25.
37. Hong DY, Lee JH, Park SO, Baek KJ, Lee KR. Plasma neutrophil gelatinase-
associated lipocalin as early biomarker for acute kidney injury in burn
patients. J Burn Care Res. 2013;34:e326–32.
38. Yang HT, Yim H, Cho YS, Kym D, Hur J, Kim JH, et al. Assessment of
biochemical markers in the early post-burn period for predicting acute
kidney injury and mortality in patients with major burn injury: comparison
of serum creatinine, serum cystatin-C, plasma and urine neutrophil
gelatinase-associated lipocalin. Crit Care. 2014;18:R151.
39. Yavuz S, Anarat A, Acarturk S, Dalay AC, Kesiktas E, Yavuz M, et al. Neutrophil
gelatinase associated lipocalin as an indicator of acute kidney injury and
inflammation in burned children. Burns. 2014;40:648–54.
40. Noshad H. Frequency and prognosis of acute kidney injury in burned
patients. Saudi J Kidney Dis Transpl. 2014;25:423–4.
41. Howell E, Sen S, Palmieri T, Godwin Z, Bockhold J, Greenhalgh D, et al.
Point-of-care B-type natriuretic peptide and neutrophil gelatinase-associated
lipocalin measurements for acute resuscitation: a pilot study. J Burn Care
Res. 2015;36:e26–33.
42. Sen S, Godwin ZR, Palmieri T, Greenhalgh D, Steele AN, Tran NK. Whole
blood neutrophil gelatinase-associated lipocalin predicts acute kidney injury
in burn patients. J Surg Res. 2015;196:382–7.
43. Ren H, Zhou X, Dai D, Liu X, Wang L, Zhou Y, et al. Assessment of urinary
kidney injury molecule-1 and interleukin-18 in the early post-burn period to
predict acute kidney injury for various degrees of burn injury. BMC Nephrol.
2015;16:142.
44. Liang J, Zhang P, Hu X, Zhi L. Elevated serum uric acid after injury correlates
with the early acute kidney in severe burns. Burns. 2015;41:1724–31.
45. Yim H, Kym D, Seo DK, Yoon J, Yang HT, Lee J, et al. Serum cystatin C and
microalbuminuria in burn patients with acute kidney injury. Eur J Clin
Investig. 2015;45:594–600.
46. Kym D, Cho YS, Yoon J, Yim H, Yang HT. Evaluation of diagnostic
biomarkers for acute kidney injury in major burn patients. Annals Surgical
Treatment Res. 2015;88:281–8.
47. Queiroz LF, Anami EH, Zampar EF, Tanita MT, Cardoso LT, Grion CM.
Epidemiology and outcome analysis of burn patients admitted to an
intensive care unit in a university hospital. Burns. 2016;42:655–62.
48. Rakkolainen I, Vuola J. Plasma NGAL predicts early acute kidney injury no
earlier than s-creatinine or cystatin C in severely burned patients. Burns.
2016;42:322–8.
49. Sanchez-Sanchez M, Garcia-de-Lorenzo A, Cachafeiro L, Herrero E, Asensio
MJ, Agrifoglio A, et al. Acute kidney injury in critically burned patients
resuscitated with a protocol that includes low doses of hydroxyethyl starch.
Annals Burns Fire Disasters. 2016;29:183–8.
50. Kuo G, Yang SY, Chuang SS, Fan PC, Chang CH, Hsiao YC, et al. Using acute
kidney injury severity and scoring systems to predict outcome in patients
with burn injury. J Formos Med Assoc. 2016;115:1046–52.
51. Hundeshagen G, Herndon DN, Capek KD, Branski LK, Voigt CD, Killion EA,
et al. Co-administration of vancomycin and piperacillin-tazobactam is
associated with increased renal dysfunction in adult and pediatric burn
patients. Crit Care. 2017;21:318.
52. Kumar AB, Andrews W, Shi Y, Shotwell MS, Dennis S, Wanderer J, et al. Fluid
resuscitation mediates the association between inhalational burn injury and
acute kidney injury in the major burn population. J Crit Care. 2017;38:62–7.
53. Kimmel LA, Wilson S, Walker RG, Singer Y, Cleland H. Acute kidney injury: it’s
not just the ‘big’ burns. Injury. 2018;49:213–8.
54. Chun W, Kim Y, Yoon J, Lee S, Yim H, Cho YS, et al. Assessment of plasma
neutrophil gelatinase-associated lipocalin for early detection of acute kidney
injury and prediction of mortality in severely burned patients. J Burn Care
Res. 2018;39:387–93.
55. Depret F, Boutin L, Jarkovsky J, Chaussard M, Soussi S, Bataille A, et al.
Prediction of major adverse kidney events in critically ill burn patients.
Burns. 2018;44:1887–94.
56. Talizin TB, Tsuda MS, Tanita MT, Kauss IAM, Festti J, Carrilho C, et al. Acute
kidney injury and intra-abdominal hypertension in burn patients in intensive
care. Revista Brasileira de Terapia Intensiva. 2018;30:15–20.
57. Kim HY, Kong YG, Park JH, Kim YK. Acute kidney injury after burn surgery:
preoperative neutrophil/lymphocyte ratio as a predictive factor. Acta
Anaesthesiol Scand. 2019;63:240–7.
58. Clark AT, Li X, Kulangara R, Adams-Huet B, Huen SC, Madni TD, et al. Acute
kidney injury after burn: a cohort study from the parkland burn intensive
care unit. J Burn Care Res. 2019;40:72–8.
59. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al.
Epidemiology of acute kidney injury in critically ill patients: the
multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–23.
60. Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;
364:k4891.
61. van den Akker JP, Egal M, Groeneveld AB. Invasive mechanical ventilation as
a risk factor for acute kidney injury in the critically ill: a systematic review
and meta-analysis. Crit Care. 2013;17:R98.
62. Lee SA, Cozzi M, Bush EL, Rabb H. Distant organ dysfunction in acute kidney
injury: a review. Am J Kidney Dis. 2018;72:846–56.
63. Husain-Syed F, Ricci Z, Brodie D, Vincent JL, Ranieri VM, Slutsky AS, et al.
Extracorporeal organ support (ECOS) in critical illness and acute kidney
injury: from native to artificial organ crosstalk. Intensive Care Med. 2018;44:
1447–59.
64. Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettila V,
Prowle JR, et al. Renal recovery after acute kidney injury. Intensive Care
Med. 2017;43:855–66.
65. Parikh A, Shaw A. The economics of renal failure and kidney disease in
critically ill patients. Crit Care Clin. 2012;28:99–111 vii.
66. Gatward JJ, Gibbon GJ, Wrathall G, Padkin A. Renal replacement therapy for
acute renal failure: a survey of practice in adult intensive care units in the
United Kingdom. Anaesthesia. 2008;63:959–66.
67. Palant CE, Patel SS, Chawla LS. Acute kidney injury recovery. Contrib
Nephrol. 2018;193:35–44.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Folkestad et al. Critical Care            (2020) 24:2 Page 11 of 11
